Is a complete BME/ART research report available?

Question

Accepted Answer

No complete published report is available for bme/ART (BME/ART) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Market cap	1.7B
Revenue (ttm)	548M
Net income (ttm)	54.7M
EPS (ttm)	€0.96
Shares out	57M
P/E (trailing)	30.0x
P/E (forward)	25.9x
Dividend	€0.17 (0.57%)
Volume	33,533

Metric	Value
Country	Spain
Country code	ES
Employees	1,880
Employees Change	158%
Employees Change Percent	9.18
Enterprise value	EUR 1.8B
Exchange	Madrid Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Electronic Components
Isin	ES0105521001
Last refreshed	2026-08-02
Market cap	EUR 1.7B
Price	EUR 29.1
Price currency	EUR
Rev Per Employee	184,762.98x
Sector	Technology
Sector PE	19.06
Sector PE Fwd	15.69
Sic	3612
Symbol	bme/ART
Website	https://www.arteche.com

Metric	Value
Earnings Yield	3.29%
EV Earnings	32.02x
EV/EBIT	53.34x
EV/EBITDA	42.15x
EV/FCF	44.05x
EV/Sales	3.19x
FCF yield	2.39%
Forward P/E	25.87x
P/B ratio	9.84x
P/E ratio	29.97x
P/S ratio	3.03x
PE Ratio3 Y	22.82x
PE Ratio5 Y	23.46x

Metric	Value
EBIT Margin	5.97%
EBITDA Margin	7.56%
FCF margin	7.25%
Gross margin	53.9%
Gross Profit	EUR 295.4M
Gross Profit Growth	23.04%
Gross Profit Growth Q	22.37%
Gross Profit Growth3 Y	24.82%
Gross Profit Growth5 Y	18.52%
Net Income	EUR 54.7M
Net Income Growth	80.42%
Net Income Growth Q	44.31%
Net Income Growth Quarters	6%
Net Income Growth Years	3%
Net Income Growth3 Y	92.32%
Net Income Growth5 Y	121.34%
Pretax Margin	12.2%
Profit Margin	9.98%
Profit Per Employee	EUR 18,432
Profitable Quarters	EUR 9
Profitable Years	7
ROA	9.65
Roa5y	5.04
ROCE	10.45
ROE	45.19
Roe5y	26.23
ROIC	26.25
Roic5y	18.12

Metric	Value
Cagr1y	155.31%
Cagr3y	99.17%
Cagr5y	50.58%
Div CAGR3	114.89%
EPS Growth	81.17
EPS Growth Q	46.8
EPS Growth Quarters	6
EPS Growth Years	3
EPS Growth3 Y	92.3
EPS Growth5 Y	115.1
FCF Growth	0.72%
FCF Growth Q	18.34%
FCF Growth3 Y	39.47%
FCF Growth5 Y	22.7%
OCF Growth	22.4%
OCF Growth Q	53.12%
OCF Growth3 Y	42.89%
OCF Growth5 Y	25.05%
Revenue Growth	18.21x
Revenue Growth Q	12.08x
Revenue Growth Quarters	6x
Revenue Growth Years	6x
Revenue Growth3 Y	15.92x
Revenue Growth5 Y	15.27x

BME/ART (BME/ART)

Coverage state: Market snapshot only — no published research

Generate the first BME/ART analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · BME/ART

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BME/ART indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BME/ART

Frequently asked questions

Metric	Value
Asset Turnover	EUR 1.13
Assets	EUR 588.4M
Cash	EUR 100.4M
Current Assets	EUR 331.4M
Current Liabilities	EUR 274.4M
Debt	EUR 180.3M
Debt EBITDA	EUR 4.34
Debt Equity	EUR 1.07
Debt FCF	EUR 4.54
Equity	EUR 168.7M
Interest Coverage	4.33
Liabilities	EUR 419.7M
Long Term Assets	EUR 257M
Long Term Liabilities	EUR 145.3M
Net Cash	EUR -80M
Net Cash By Market Cap	EUR -4.82
Net Debt EBITDA	EUR 1.93
Net Debt Equity	EUR 0.47
Net Debt FCF	EUR 2.01
Tangible Book Value	EUR 80.5M
Tangible Book Value Per Share	EUR 1.41
WACC	6.97

Metric	Value
Current ratio	1.21
Inventory Turnover	2.68
Net Working Capital	EUR 14.4M
Quick ratio	0.81
Working Capital	EUR 57M
Working Capital Turnover	EUR 9.74

Metric	Value
Buyback Yield	-0.2%
Dividend Growth	139.81%
Dividend Growth Years	2%
Dividend per share	EUR 0.17
Dividend Years	5
Dividend Yield	0.57%
Ex Div Date	2026-05-08
Last Dividend	EUR 0.32
Payout Frequency	Annual
Payout Ratio	33.58%

Metric	Value
1Y total return	155.15%
200-day SMA	27.58
3Y total return	690.48%
50-day SMA	34.44
50-day SMA vs 200-day SMA	50over200
5Y total return	673.89%
All Time High	46
All Time High Change	-36.74%
All Time High Date	2026-05-12
All Time Low	2.74
All Time Low Change	962.04%
All Time Low Date	2022-04-26
ATR	1.72
Beta	0.56
Beta1y	0.43
Beta2y	0.37
Ch YTD	28.76
High	30
High52	46
High52 Date	2026-05-13
High52ch	-36.74%
Low	28.7
Low52	11.2
Low52 Date	2025-08-04
Low52ch	159.82%
Ma50ch	-15.51%
Price vs 200-day SMA	5.53%
RSI	38.5
RSI Monthly	66.23
RSI Weekly	47.52
Sharpe ratio	2.05x
Sortino ratio	3.64
Total Return	0.36%
Tr YTD	29.83
Tr1m	-13.65%
Tr1w	-4.9%
Tr3m	-8.02%

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Operating Income	EUR 75.2M
Operating Income Growth	45.4
Operating Income Growth Q	34.14
Operating Income Growth3 Y	108
Operating Income Growth5 Y	36.32
Operating margin	13.72
Price target	EUR 34.25
Price Target Change	EUR 17.7

Metric	Value
Float	9,968,889%
Net Borrowing	34,813,000
Shares Institutions	15.05%
Shares Out	57,038,882
Shares Qo Q	-0.23%
Shares Yo Y	0.2%

Metric	Value
Average Volume	39,147.15x
Bv Per Share	2.77
CAPEX	EUR -23.6M
Ch1m	-13.65
Ch1w	-4.9
Ch1y	153
Ch3m	-8.78
Ch3y	657.8
Ch5y	627.5
Ch6m	25.43
Change	-1.36%
Change From Open	-1.36
Close	29.5
Days Gap	0
Depreciation Amortization	10,118,000
Dollar Volume	975,810.3
Earnings Date	2026-07-28
EBIT	EUR 32.8M
EBITDA	EUR 41.5M
EPS	EUR 0.96
F Score	5
FCF	EUR 39.7M
FCF EV Yield	2.27x
FCF Per Share	EUR 0.7
Financing CF	48,265,000
Fiscal Year End	December
Founded	1,946
Goodwill	66,995,000
Graham Number	7.72347
Graham Upside	-73.46
Income Tax	EUR 8.8M
Investing CF	-98,162,000
Is Primary Listing	1
Last Earnings Date	2026-07-28
Last Report Date	2026-06-30
Lynch Fair Value	EUR 23.93
Lynch Upside	-17.76
Ma150	29.84
Ma150ch	-2.49%
Ma20	30.87
Ma20ch	-5.72%
Net CF	13,487,000
Next Earnings Date	2026-09-07
Open	29.5
P FCF Ratio	41.77
P OCF Ratio	26.19
Payment Date	2026-05-12
Position In Range	30.77
Ppne	94,420,000
Price Date	2026-07-31
Price EBITDA	EUR 39.97
Ptbv Ratio	20.62
Relative Volume	0.88x
Revenue	548,007,000x
Tax By Revenue	1.61x
Tax Rate	13.17%
Tr6m	26.47%
Volume	33,533
Z Score	3.55